- Home
- ATCH vs INMB Comparison
ATCH vs INMB Comparison
Compare ATCH & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCH | INMB |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.5M | 37.2M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ATCH | INMB |
|---|---|---|
| Price | $0.21 | $1.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $1.00 | ★ $5.40 |
| AVG Volume (30 Days) | ★ 1.5M | 471.5K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | $84.47 | N/A |
| Revenue Next Year | $39.32 | N/A |
| P/E Ratio | $4.27 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.14 | $1.09 |
| 52 Week High | $1.92 | $11.64 |
Technical Indicators
Market Signals| Indicator | ATCH | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 35.28 | 37.71 |
| Support Level | $0.18 | $1.15 |
| Resistance Level | $0.21 | $1.50 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 1.75 | 6.93 |
Price Performance
Historical ComparisonAbout ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.